These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1941709)

  • 1. Negative symptoms and reaction time in schizophrenia.
    Schwartz F; Munich RL; Carr A; Bartuch E; Lesser B; Rescigno D; Viegener B
    J Psychiatr Res; 1991; 25(3):131-40. PubMed ID: 1941709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative priming (cognitive inhibition) in psychiatric patients: effect of neuroleptics.
    David AS
    J Nerv Ment Dis; 1995 May; 183(5):337-9. PubMed ID: 7745390
    [No Abstract]   [Full Text] [Related]  

  • 3. Shifts in covert visual attention in schizophrenic patients and normal controls.
    Moran MJ; Thaker GK; Smith D; Cassady S; Layne-Gedge J
    Biol Psychiatry; 1992 Oct; 32(7):617-20. PubMed ID: 1450288
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery.
    Goldberg TE; Gold JM; Greenberg R; Griffin S; Schulz SC; Pickar D; Kleinman JE; Weinberger DR
    Am J Psychiatry; 1993 Sep; 150(9):1355-62. PubMed ID: 8352346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of cognitive and motor slowing in the Digit Symbol Test (DST): differences between depression and schizophrenia.
    van Hoof JJ; Jogems-Kosterman BJ; Sabbe BG; Zitman FG; Hulstijn W
    J Psychiatr Res; 1998; 32(2):99-103. PubMed ID: 9694005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).
    Lançon C; Auquier P; Reine G; Bernard D; Toumi M
    J Affect Disord; 2000 May; 58(2):107-15. PubMed ID: 10781700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-latency auditory event-related potentials in schizophrenia and in bipolar and unipolar affective disorder.
    Muir WJ; St Clair DM; Blackwood DH
    Psychol Med; 1991 Nov; 21(4):867-79. PubMed ID: 1780401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.
    Lewine RR
    Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased blink rate in drug-naive acute schizophrenic patients.
    Mackert A; Woyth C; Flechtner KM; Volz HP
    Biol Psychiatry; 1990 Jun; 27(11):1197-202. PubMed ID: 2354226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and cognitive factors associated with verbal memory task performance in patients with schizophrenia.
    Brébion G; Gorman JM; Malaspina D; Sharif Z; Amador X
    Am J Psychiatry; 2001 May; 158(5):758-64. PubMed ID: 11329399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigilance deficits in schizophrenics and affectively disturbed patients.
    Rund BR; Orbeck AL; Landrø NI
    Acta Psychiatr Scand; 1992 Sep; 86(3):207-12. PubMed ID: 1414414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenic patients with depression: psychopathological profiles and relationship with negative symptoms.
    Lindenmayer JP; Grochowski S; Kay SR
    Compr Psychiatry; 1991; 32(6):528-33. PubMed ID: 1778080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of secondary depression in schizophrenia.
    Becker RE; Colliver JA; Verhulst SJ
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):4-8. PubMed ID: 4055721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of reaction time in post-acute schizophrenia using electrophysiologic variables].
    Eichert V; Klosterkötter J
    Fortschr Neurol Psychiatr; 1996 Jul; 64(7):261-70. PubMed ID: 8765892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive and negative symptoms and social competence in adolescents at risk for schizophrenia and affective disorder.
    Dworkin RH; Green SR; Small NE; Warner ML; Cornblatt BA; Erlenmeyer-Kimling L
    Am J Psychiatry; 1990 Sep; 147(9):1234-6. PubMed ID: 2386257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential visual information processing between schizophrenics and other psychiatric populations.
    Schwartz BD; Satter EK; O'Neill PT; Winstead DK
    Schizophr Res; 1989; 2(4-5):325-31. PubMed ID: 2487173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.